Targeted Therapies In R/R Myeloma: Novel Approaches Being Explored

Targeted therapies in R/R myeloma: novel approaches being explored

VJHemOnc – Video Journal of Hematology & HemOnc

Novel targets being explored in multiple myeloma and the value of CELMoDs

VJHemOnc – Video Journal of Hematology & HemOnc

Novel Treatment Strategies in R/R Multiple Myeloma

Targeted Oncology

Upcoming therapeutic approaches in the R/R myeloma space

VJHemOnc – Video Journal of Hematology & HemOnc

Treatment Approaches in R/R Myeloma

Targeted Oncology

What targets are being explored for antibody therapy? #myeloma

HealthTree University for Multiple Myeloma

Novel Approaches for the Treatment of Classical HL

Targeted Oncology

Approaching R/R multiple myeloma: novel agents and immunotherapies

VJHemOnc – Video Journal of Hematology & HemOnc

ASH 2020: Targeted therapies in r/r multiple myeloma

GPRC5D and FCRH5 Targeted Therapies in Myeloma

HealthTree Foundation for Multiple Myeloma

Caring for Patients on IRd Therapy in R/R Multiple Myeloma

Targeted Oncology

The Challenges of Treating R/R Myeloma

Targeted Oncology

Real-world treatment patterns in third-line therapy for R/R myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Managing progression after BCMA-targeted therapy in R/R multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Integrating BCMA-targeted agents in earlier lines of therapy for R/R multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. James R. Berenson Gives an Overview of Targets in Myeloma

Targeted Oncology

Real-world safety and efficacy of talquetamab for the treatment of R/R myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Paul Richardson on novel approaches for treating multiple myeloma | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Novel approaches in newly diagnosed myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Progress in the Treatment of R/R Multiple Myeloma

Targeted Oncology